KEQU
Kewaunee Scientific Corporation
KEQU trails on the overall score without a compensating advantage in the available component scores.
TSLA
Tesla, Inc.
TSLA has the edge over KEQU overall, supported by stronger fundamentals and stronger modeled upside.
KEQU Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
KEQU's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
KEQU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.5x | $20.79 | -42% |
| Fair | 11x | $29.03 | -19% |
| Expensive | 13x | $36.49 | +1.5% |
| Current | 13x | $35.94 | — |
Historical ranges are pointers, not guarantees.
KEQU has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
KEQU Forward outlook
There aren't enough analyst estimates for KEQU to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
KEQU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.76 | -33% |
| Q2 2026 | $3.22 | -16% |
| Q1 2026 | $3.72 | -37% |
| Q4 2025 | $3.94 | -38% |
| Q3 2025 | $4.13 | -34% |
| Q2 2025 | $3.83 | -40% |
| Q1 2025 | $5.94 | +98% |
| Q4 2024 | $6.34 | +164% |
KEQU has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
KEQU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $66.3M | -6.7% |
| Q2 2026 | $71.4M | -7.5% |
| Q1 2026 | $69.4M | +3.3% |
| Q4 2025 | $70.1M | +47% |
| Q3 2025 | $71.1M | +47% |
| Q2 2025 | $77.1M | +36% |
| Q1 2025 | $67.2M | +44% |
| Q4 2024 | $47.8M | -5.3% |
KEQU has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.8% | -2 points |
| Q2 2026 | 7.3% | -3.7 points |
| Q1 2026 | 3.7% | +0.4 points |
| Q4 2025 | 5.9% | -3.4 points |
| Q3 2025 | 6.8% | +1.4 points |
| Q2 2025 | 11% | +1.2 points |
| Q1 2025 | 3.4% | -4.8 points |
| Q4 2024 | 9.3% | -0.9 points |
KEQU has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
KEQU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -76% |
| Q2 2026 | $4.5M | -49% |
| Q1 2026 | $11M | +$13.9M |
| Q4 2025 | -$5.8M | -175% |
| Q3 2025 | $5M | +$6.1M |
| Q2 2025 | $8.9M | +5256% |
| Q1 2025 | -$3M | -133% |
| Q4 2024 | $7.8M | +$8.3M |
KEQU has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
KEQU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -62K shares |
| 1 year | -1.4% | -42K shares |
| 3 years | +1.2% | +36K shares |
| 5 years | +5.2% | +144K shares |
| Available history | +6.2% | +171K shares |
KEQU has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $529,000 |
| Q2 2025 | $1.6M |
| Q2 2024 | $1.2M |
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
KEQU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | -1.3x | Net Cash |
KEQU's net debt is less than a year of its operating earnings (EBITDA).
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over KEQU on leverage, with a lower net debt burden relative to earnings.
KEQU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 35.7 | Neutral |
KEQU's weekly RSI is 51 (neutral) and its Stochastic is 36 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
KEQU PE vs Consumer Cyclical Sector
| Metric | KEQU | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 28% below |
| PE % | 81 | 47 | 34 pts above |
KEQU has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
KEQU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.9 | 6% above |
| 20 week MA | $35.4 | 1.5% above |
| 50 week MA | $37.0 | 2.9% below |
| 100 week MA | $42.5 | 15% below |
| 200 week MA | $35.1 | 2.4% above |
KEQU's trend is mixed: it's above three of its five weekly moving averages, and 2.4% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over KEQU on trend strength, trading above more of its moving averages.
KEQU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.1 | $10.6 | -19% |
| 2021 | $10.6 | $12.3 | +16% |
| 2022 | $12.3 | $15.8 | +28% |
| 2023 | $15.8 | $29.1 | +85% |
| 2024 | $29.1 | $63.8 | +120% |
| 2025 | $63.8 | $38.0 | -40% |
| 2026 YTD | $38.0 | $35.9 | -5.4% |
KEQU has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.